Source:http://linkedlifedata.com/resource/pubmed/id/21088498
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2011-1-20
|
pubmed:abstractText |
?Np63?, the dominant negative isoform of the p63 family is an essential survival factor in head and neck squamous cell carcinoma. This isoform has been shown to be down regulated in response to several DNA damaging agents, thereby enabling an effective cellular response to genotoxic agents. Here, we identify a key molecular mechanism underlying the regulation of ?Np63? expression in response to extrinsic stimuli, such as chemotherapeutic agents. We show that ?Np63? interacts with NF-?? in presence of cisplatin. We find that NF-?? promotes ubiquitin-mediated proteasomal degradation of ?Np63?. Chemotherapy-induced stimulation of NF-?? leads to degradation of ?Np63? and augments trans-activation of p53 family-induced genes involved in the cellular response to DNA damage. Conversely, inhibition of NF-?? with siRNA-mediated silencing NF-?? expression attenuates chemotherapy induced degradation of ?Np63? . These data demonstrate that NF-?? plays an essential role in regulating ?Np63? in response to extrinsic stimuli. Our findings suggest that the activation of NF-?? may be a mechanism by which levels of ?Np63? are reduced, thereby rendering the cells susceptible to cell death in the face of cellular stress or DNA damage.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/TP63 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor RelA,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1551-4005
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4841-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21088498-Cell Line, Tumor,
pubmed-meshheading:21088498-Gene Expression Regulation,
pubmed-meshheading:21088498-Head and Neck Neoplasms,
pubmed-meshheading:21088498-Humans,
pubmed-meshheading:21088498-Proteasome Endopeptidase Complex,
pubmed-meshheading:21088498-Protein Isoforms,
pubmed-meshheading:21088498-RNA Interference,
pubmed-meshheading:21088498-Trans-Activators,
pubmed-meshheading:21088498-Transcription, Genetic,
pubmed-meshheading:21088498-Transcription Factor RelA,
pubmed-meshheading:21088498-Transcription Factors,
pubmed-meshheading:21088498-Tumor Suppressor Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Regulation of ?Np63? by NF??.
|
pubmed:affiliation |
Department of Otolaryngology-Head and Neck Surgery, Division of Head and Neck Cancer Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|